2026-05-29 Sumitomo Pharma Co.,Ltd. “The "Notice of Convocation of the 206th Ordinary General Meeting of Shareholders" is posted.”
2026-05-29 Sumitomo Pharma Co.,Ltd. “The "Notice of Convocation of the 206th Ordinary General Meeti … 続きを読む
JP3495000006
2026-05-22 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Results of the Third-Party Allotment of Shares (Not Implemented).”
2026-05-22 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Results of the Third-Party Allotment of Shares … 続きを読む
2026-05-14 Sumitomo Pharma Co.,Ltd. “The audio recording of the "Fiscal Year 2025 (Ending March 2026) Financial Results Briefing" is now available.”
2026-05-14 Sumitomo Pharma Co.,Ltd. “The audio recording of the "Fiscal Year 2025 (Ending March 202 … 続きを読む
2026-04-27 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Withdrawal of Registration for the Issuance of New Shares.”
2026-04-27 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Withdrawal of Registration for the Issuance of … 続きを読む
2026-04-20 Sumitomo Pharma Co.,Ltd. “Notice regarding the determination of the issue price and selling price, etc.”
2026-04-20 Sumitomo Pharma Co.,Ltd. “Notice regarding the determination of the issue price and selling p … 続きを読む
2026-04-20 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Determination of the Issue Price, etc. (Public Notice Based on Article 15, Paragraph 5 of the Financial Instruments and Exchange Act).”
2026-04-20 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Determination of the Issue Price, etc. (Public … 続きを読む
2026-04-08 Sumitomo Pharma Co.,Ltd. “Notice regarding the issuance of new shares and the sale of existing shares.”
2026-04-08 Sumitomo Pharma Co.,Ltd. “Notice regarding the issuance of new shares and the sale of existin … 続きを読む
2026-04-08 Sumitomo Pharma Co.,Ltd. “Notice regarding the refinancing of existing debt through a bridge loan.”
2026-04-08 Sumitomo Pharma Co.,Ltd. “Notice regarding the refinancing of existing debt through a bridge … 続きを読む
2026-03-30 Sumitomo Pharma Co.,Ltd. “Regarding the application for approval of a partial change in the dosage and administration of the atypical antipsychotic drug "Latuda" for pediatric use in schizophrenia in Japan.”
2026-03-30 Sumitomo Pharma Co.,Ltd. “Regarding the application for approval of a partial change in the d … 続きを読む
2026-03-25 Sumitomo Pharma Co.,Ltd. “Notice Regarding Recognition of Non-Operating Income in Our Standalone Financial Statements (Japanese GAAP).”
2026-03-25 Sumitomo Pharma Co.,Ltd. “Notice Regarding Recognition of Non-Operating Income in Our Standal … 続きを読む